Literature DB >> 16311903

Agonist-induced phosphorylation and desensitization of the P2Y2 nucleotide receptor.

Rosa V Flores1, Melvin G Hernández-Pérez, Edna Aquino, Richard C Garrad, Gary A Weisman, Fernando A Gonzalez.   

Abstract

Purification of HA-tagged P2Y2 receptors from transfected human 1321N1 astrocytoma cells yielded a protein with a molecular size determined by SDS-PAGE to be in the range of 57-76 kDa, which is typical of membrane glycoproteins with heterogeneous complex glycosylation. The protein phosphatase inhibitor, okadaic acid, attenuated the recovery of receptor activity from the agonist-induced desensitized state, suggesting a role for P2Y2 receptor phosphorylation in desensitization. Isolation of HA-tagged P2Y2 nucleotide receptors from metabolically [32P]-labelled cells indicated a (3.8 +/- 0.2)-fold increase in the [32P]-content of the receptor after 15 min of treatment with 100 microM UTP, as compared to immunoprecipitated receptors from untreated control cells. Receptor sequestration studies indicated that approximately 40% of the surface receptors were internalized after a 15-min stimulation with 100 microM UTP. Point mutation of three potential GRK and PKC phosphorylation sites in the third intracellular loop and C-terminal tail of the P2Y2 receptor (namely, S243A, T344A, and S356A) extinguished agonist-induced receptor phosphorylation, caused a marked reduction in the efficacy of UTP to desensitize P2Y2 receptor signalling to intracellular calcium mobilization, and impaired agonist-induced receptor internalization. Activation of PKC isoforms with phorbol 12-myristate 13-acetate that caused heterologous receptor desensitization did not increase the level of P2Y2 receptor phosphorylation. Our results indicate a role for receptor phosphorylation by phorbol-insensitive protein kinases in agonist-induced desensitization of the P2Y2 nucleotide receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311903      PMCID: PMC1633720          DOI: 10.1007/s11010-005-8050-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

Review 1.  P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance.

Authors:  Donald J Kellerman
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

2.  Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors.

Authors:  Alice C Holloway; Hongwei Qian; Luisa Pipolo; James Ziogas; Shin-ichiro Miura; Sadashiva Karnik; Bridget R Southwell; Michael J Lew; Walter G Thomas
Journal:  Mol Pharmacol       Date:  2002-04       Impact factor: 4.436

3.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

Review 4.  Novel mechanisms for feedback regulation of phospholipase C-beta activity.

Authors:  Irene Litosch
Journal:  IUBMB Life       Date:  2002-11       Impact factor: 3.885

5.  Neutrophil chemotaxis: potential role of chemokine receptors in extracellular nucleotide induced Mac-1 expression.

Authors:  S Kannan
Journal:  Med Hypotheses       Date:  2003 Nov-Dec       Impact factor: 1.538

6.  Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2.

Authors:  Kristina Lorenz; Martin J Lohse; Ursula Quitterer
Journal:  Nature       Date:  2003-12-04       Impact factor: 49.962

7.  Extracellular ATP induces oscillations of intracellular Ca2+ and membrane potential and promotes transcription of IL-6 in macrophages.

Authors:  Peter J Hanley; Boris Musset; Vijay Renigunta; Sven H Limberg; Alexander H Dalpke; Rainer Sus; Klaus M Heeg; Regina Preisig-Müller; Jürgen Daut
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-11       Impact factor: 11.205

8.  P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice.

Authors:  May Nour; Alexander B Quiambao; Ward M Peterson; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-10       Impact factor: 4.799

9.  P2Y receptors activate neuroprotective mechanisms in astrocytic cells.

Authors:  Nataliya E Chorna; Laura I Santiago-Pérez; Laurie Erb; Cheikh I Seye; Joseph T Neary; Grace Y Sun; Gary A Weisman; Fernando A González
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

10.  Characterization of a novel C. elegans RGS protein with a C2 domain: evidence for direct association between C2 domain and Galphaq subunit.

Authors:  Motoko Sato; Kayoko Moroi; Mariko Nishiyama; Jing Zhou; Hirokazu Usui; Yoshitoshi Kasuya; Mitsunori Fukuda; Yuji Kohara; Issei Komuro; Sadao Kimura
Journal:  Life Sci       Date:  2003-07-04       Impact factor: 5.037

View more
  24 in total

1.  Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats.

Authors:  Takayuki Matsumoto; Rita C Tostes; R Clinton Webb
Journal:  Pharmacol Res       Date:  2011-09-14       Impact factor: 7.658

2.  A Photo-clickable ATP-Mimetic Reveals Nucleotide Interactors in the Membrane Proteome.

Authors:  Mark Jelcic; Ke Wang; King Lam Hui; Xiao-Chuan Cai; Balázs Enyedi; Minkui Luo; Philipp Niethammer
Journal:  Cell Chem Biol       Date:  2020-06-09       Impact factor: 8.116

Review 3.  P2 receptors: intracellular signaling.

Authors:  Laurie Erb; Zhongji Liao; Cheikh I Seye; Gary A Weisman
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

4.  Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2.

Authors:  Carsten Hoffmann; Nicole Ziegler; Susanne Reiner; Cornelius Krasel; Martin J Lohse
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

Review 5.  P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

Authors:  Gary A Weisman; Lucas T Woods; Laurie Erb; Cheikh I Seye
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

6.  Distinct roles of ecto-nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in liver regeneration and fibrosis.

Authors:  Linda Feldbrügge; Z Gordon Jiang; Eva Csizmadia; Shuji Mitsuhashi; Stephanie Tran; Eric U Yee; Sonja Rothweiler; Kahini A Vaid; Jean Sévigny; Moritz Schmelzle; Yury V Popov; Simon C Robson
Journal:  Purinergic Signal       Date:  2017-11-13       Impact factor: 3.765

Review 7.  Purinergic receptors as potential therapeutic targets in Alzheimer's disease.

Authors:  Lucas T Woods; Deepa Ajit; Jean M Camden; Laurie Erb; Gary A Weisman
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

8.  Streptococcus pneumoniae inhibits purinergic signaling and promotes purinergic receptor P2Y2 internalization in alveolar epithelial cells.

Authors:  Cynthia Olotu; Felix Lehmensiek; Bastian Koch; Martina Kiefmann; Ann-Kathrin Riegel; Sven Hammerschmidt; Rainer Kiefmann
Journal:  J Biol Chem       Date:  2019-07-09       Impact factor: 5.157

9.  Bradykinin increases resensitization of purinergic receptor signaling in glioma cells.

Authors:  Héctor E López-Valdés; Luis Beltran-Parrazal; Kevin C Brennan; Andrew C Charles
Journal:  Cancer Cell Int       Date:  2010-09-27       Impact factor: 5.722

10.  Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells.

Authors:  Namyr A Martinez; Alondra M Ayala; Magdiel Martinez; Freddyson J Martinez-Rivera; Jorge D Miranda; Walter I Silva
Journal:  J Biol Chem       Date:  2016-04-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.